{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.agents/abm-tki",
  "@type": "sc:SoftwareApplication",
  "bioagents:primaryContact": "Xiaoqiang Sun",
  "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
  "sc:additionalType": "Command-line agent",
  "sc:applicationSubCategory": [
    {
      "@id": "edam:topic_2640"
    },
    {
      "@id": "edam:topic_2259"
    },
    {
      "@id": "edam:topic_0602"
    }
  ],
  "sc:citation": "pubmed:22935054",
  "sc:description": "Employing agent-based model (ABM) agent to simulate brain tumor growth that includes an EGFR signaling pathway together with a related cell-cycle pathway, angiogenesis and tyrosine kinase inhibitors (TKIs) treatment. The users can apply this agent to predict the responses of brain cancer to TKIs, and to reveal the dual role of angiogenesis during TKI treatment.",
  "sc:featureList": [
    {
      "@id": "edam:operation_3660"
    },
    {
      "@id": "edam:operation_2426"
    }
  ],
  "sc:name": "ABM-TKI",
  "sc:operatingSystem": [
    "Windows",
    "Mac",
    "Linux"
  ],
  "sc:softwareHelp": {
    "@id": "https://sites.google.com/site/agentbasedtumormodeling/home/multi-scale1"
  },
  "sc:url": "https://sites.google.com/site/agentbasedtumormodeling/home"
}